EurekAlert!5d
C-Path’s predictive safety testing consortium advances a transformative test to detect drug induced liver injury
Researchers from Critical Path Institute’s Predictive Safety Testing Consortium have proposed glutamate dehydrogenase (GLDH) as a more liver-specific biomarker for detecting liver injury, supporting ...
Consortium advances a test to detect drug-induced liver injury
Predictive Safety Testing Consortium have proposed glutamate dehydrogenase (GLDH) as a more liver-specific biomarker for ...